anticancer compounds (Mycosynthetix/University of North Carolina/North Carolina Central University/Ohio State University/University of Illinois/RTI International/Bristol-Myers Squibb Pharmaceutical Research Intitute)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameanticancer compounds (Mycosynthetix/University of North Carolina/North Carolina Central University/Ohio State University/University of Illinois/RTI International/Bristol-Myers Squibb Pharmaceutical Research Intitute)
Drug Alias Nameanticancer compounds (Mycosynthetix/University of North Carolina/North Carolina Central University/Ohio State University/University of Illinois/Research Triangle Institute/Bristol-Myers Squibb Pharmaceutical Research Intitute)
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMycosynthetix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorth Carolina Central UniversityUniversity Of North Carolina, GreensboroMycosynthetix Inc +[7] 
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A